H.R.5313: To enhance competition for prescription drugs by increasing the ability of the Department of Justice and Federal Trade Commission to enforce existing antitrust laws regarding brand name drugs and generic drugs.

About This Bill

• See it on GovTrack
• See it on C-SPAN

• This bill was introduced in the 106th Congress
• This bill is primarily about law
• Introduced Sept. 27, 2000
• Latest Major Action Oct. 20, 2000
• See the one similar bills introduced in other congresses.

Bill Sponsor

• Robert E. Andrews (D-N.J.)